NFL Biosciences SA (EPA:ALNFL)
France · Delayed Price · Currency is EUR 1.110
+0.028 (2.59%)
Feb 20, 2026, 5:23 PM CET
NFL Biosciences Market Cap
NFL Biosciences has a market cap or net worth of €14.07 million as of February 20, 2026. Its market cap has decreased by -19.75% in one year.
Market Cap
14.07M
Enterprise Value
11.99M
Revenue
164.00
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.11
Market Cap Chart
Since July 5, 2021, NFL Biosciences's market cap has decreased from 19.47M to 14.07M, a decrease of -27.76%. That is a compound annual growth rate of -6.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 14.07M | -5.77% |
| Dec 31, 2025 | 14.93M | -21.92% |
| Dec 31, 2024 | 19.12M | 63.78% |
| Dec 29, 2023 | 11.67M | 13.49% |
| Dec 30, 2022 | 10.29M | -18.13% |
| Dec 31, 2021 | 12.56M | -35.48% |
| Jul 5, 2021 | 19.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nicox | 36.57M |
| Advicenne | 30.11M |
| genOway Société anonyme | 22.77M |
| Aelis Farma | 18.76M |
| GenSight Biologics | 17.95M |
| Poxel | 14.78M |
| Plant Advanced Technologies | 9.36M |
| Oncodesign Precision Medicine Société anonyme | 9.04M |